Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine versus sufentanil with ultra-low-dose isobaric bupivacaine for postoperative pain after hip fracture surgery
2022-003178-22Phase 4Terminated
- Sponsor
- Unknown at this point Between jobs
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pain and hip fracture comparing Intrathecal morphine + bupivacaine with Intrathecal sufentanil + bupivacaine (2 arms). Primary endpoints: Pain, Efficacy of spinal anesthesia and 3 more. Started Sep 2022; status: terminated.
02
Drugs
morphinesufentanilbupivacaine
03
Conditions
painhip fracture
Beyond the preview
Go deeper on 2022-003178-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003178-22.